🚨Happening in 1 hour! 🚨 Join experts on #EASLStudio as they tackle prevalence, disparities, and policy gaps in protecting young adults from #SLD. 📅Wednesday, 10 December | 18:00 CET 🔗 https://t.co/sHyYFpQVur @sagizelber @ZobairYounossi @DrCarina_FB @DebbieShawcros1

@SagiZelber @ZobairYounossi @DrCarina_FB @DebbieShawcros1 @EASLnews Don't miss the final episode of #EASLStudio Season 9 next week bringing you key insights from the 2025 @EASLNews–@AASLDtweets Consensus Conference on #PBC 📅Wednesday, 19 December 2025 | 18:00 CET 🔗 https://t.co/Fn8yruLxXb @Analleo @Mcarbone_80 @LiverNotFighter @DavidTrampert

@SagiZelber @ZobairYounossi @DrCarina_FB @DebbieShawcros1 Easy access to unhealthy food and alcohol is accelerating the SLD crisis. 🍔🍷 These aren’t separate issues , they fuel each other. The societal cost is huge, and prevention must start in childhood. 👶🛡️ @EASLNews @sagizelber @ZobairYounossi @DrCarina_FB #EASLStudio #SLD #LiverX

@SagiZelber @ZobairYounossi @DrCarina_FB @DebbieShawcros1 🍷📱We’re constantly bombarded, especially online, with alcohol marketing. Effective policies matter: higher taxes and prices reduce consumption, and limiting availability helps too. Young people need environments that protect them, not push them toward drinking.

@SagiZelber @ZobairYounossi @DrCarina_FB @DebbieShawcros1 How do we start conversations with young people about alcohol use? 🤔 🗣️Just ask, the first step is often the hardest, especially when the harms of alcohol are underestimated. Unlike tobacco, alcohol has no warning labels, despite being a Group 1 carcinogen. This fuels confusion

@SagiZelber @ZobairYounossi @DrCarina_FB @DebbieShawcros1 ⚠️Alcohol harms young people earlier and more severely than other risk factors. Heavy drinking has even been observed in individulas as young as 11, leading to injuries, accidents, and rising mortality. 📊Gender patterns are shifting too: in many countries, young girls now drink

@SagiZelber @ZobairYounossi @DrCarina_FB @DebbieShawcros1 #SLD is a dynamic spectrum. Patients often shift between #MASLD and #MetALD, so assessing alcohol use and metabolic risk is key to guiding treatment. @sagizelber @ZobairYounossi @DrCarina_FB #EASLStudio #LiverX

Stop guessing Incoterms. Grab our free quick-reference sheets and know exactly who owns cost + risk on every move. → Click for free download

@SagiZelber @ZobairYounossi @DrCarina_FB @DebbieShawcros1 #SLD is on the rise, especially in young adults. Today on #EASLStudio: What clinical and public health steps can help turn the tide? Join us now! 🔗 https://t.co/sHyYFpQVur @sagizelber @ZobairYounossi @DrCarina_FB #SLD #LiverX

In an @EASLedu & @AASLDtweets masterclass, we discussed between being resilient vs stubborn. A resilient person focuses on a meaningful goal, and keeps moving forward despite obstacles. A stubborn person keeps pushing toward an unreachable aim, even when there are better paths.

@DebbieShawcros1 @saulkarpen @allisonkwong @NoureddinMD @EASLnews 🧑‍⚕️ What can clinicians do in practice to prevent SLD in young adults? Easy-to-use screening tools and interventions will be discussed in next week’s #EASLStudio. 📅 Wednesday, 10 December | 18:00 CET 🔗 https://t.co/sHyYFpQnET @SagiZelber @DrCarina_FB @ZobairYounossi

@DebbieShawcros1 @saulkarpen @allisonkwong @NoureddinMD @EASLnews What about non-invasive tests (NITs) in the hepatology community? 🤔 How can we asses liver disease without doing a liver biopsy? 📊 Data supporting the role of NITs is emerging at fast pace 🧪 While liver biopsy is still required in Phase III trials, things are evolving 🎤

The Leon Schiff Lecture was delivered by Elliot Tapper who spoke on "Symptom Science" and improving patient reported outcomes such as itch, fatigue and cramps with largely non-pharmaceutics such as Pickle Juice. @DebbieShawcros1 @saulkarpen @allisonkwong @NoureddinMD @EASLnews

👉🏽 What is your standout highlight from The Liver Meeting? • The opening ceremony: Grace Su was joined by Former NIH Director Francis Collins who spoke on: “The Best of Times and The Worst of Times - Hope and a Plan for Action” • A wonderful post-graduate course themed "A

From liver cancer to #MASLD & #ALD, the latest breakthroughs are in! 🎥🎬🔴 LIVE NOW - Join #EASLStudio for an expert round-up of the biggest highlights from #TLM25: https://t.co/jxAQBmjsfV @DebbieShawcros1 @saulkarpen @allisonkwong @NoureddinMD @EASLnews @AASLDtweets

🚨 Missed #TLM25? We’ve got you covered! Watch #EASLStudio in 1 hour as experts decode the key findings & trends shaping hepatology from this year’s AASLD The Liver Meeting. 📅 Wednesday, 3 December | 18:00 CET 🔗 https://t.co/jxAQBmjsfV @DebbieShawcros1 @saulkarpen

Thank you @bmj_latest for dedicating this week’s issue to liver disease and the 🌊 that is upon us. This issue: 👉Identifying liver disease in primary care 👉Global patterns of youth alcohol consumption 👉Interpreting liver blood tests @LiverTrust @BASLedu @EASLEUAffairs

MASH, transplant, AI, pediatrics, global trends, #TLM25 had it all!🤩 Catch the highlights and what they mean for hepatology in 2026 and beyond in this episode of #EASLStudio 📅Wednesday, 03 December | 18:00CET 🔗 https://t.co/OEnDtFPvKG @DebbieShawcros1 @saulkarpen

From #MASLD and #ALD to liver cancer and beyond, join us next week as EASL Studio discusses key studies presented at the @AASLDTweets #TLM25 🗓️Wednesady 3 Dcember | 18:00 CET 🔗 https://t.co/OEnDtFPvKG @DebbieShawcros1 @saulkarpen @allisonkwong @NoureddinMD @FrancqueSven

🥗 Nutrition is often overlooked. The gut microbiome depends on what patients can absorb and precision nutrition may help support better outcomes. 🔬 Combinatorial therapies are the future. Studies should track rifaximin use more closely, including duration, other antibiotics and

🧪 Point-of-care testing for antimicrobial resistance is urgently needed. We still lack rapid diagnostics for AMR, costing valuable time and lives. 🔬Molecular techniques could help us identify pathogens and resistance genes on the same day, allowing clinicians to move straight